Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) filed a Form 8-K with the Securities and Exchange Commission on January 30, 2026, disclosing a material event.
Aspire Biopharma Holdings, Inc.'s stock currently trades at $2.13 with a market capitalization of $5.2M. The Healthcare company's stock moved following the disclosure.